Calydial, Site de Vienne, CH Lucien Hussel Report issue

Academic/Hospital Phase 3

Organization Overview

First Clinical Trial
2017
NCT03083184
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2017

Timeline

NOW
  • Now

Alternative names

Calydial - CH Viennes